Enovis EBITDA Margin 2011-2025 | ENOV
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Enovis (ENOV) over the last 10 years. The current EBITDA margin for Enovis as of September 30, 2025 is .
| Enovis EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $2.19B | $0.18B | 8.17% |
| 2025-03-31 | $2.15B | $0.15B | 6.79% |
| 2024-12-31 | $2.11B | $0.16B | 7.55% |
| 2024-09-30 | $2.00B | $0.15B | 7.50% |
| 2024-06-30 | $1.91B | $0.15B | 7.63% |
| 2024-03-31 | $1.82B | $0.16B | 8.97% |
| 2023-12-31 | $1.71B | $0.15B | 8.90% |
| 2023-09-30 | $1.66B | $0.13B | 7.52% |
| 2023-06-30 | $1.63B | $0.12B | 7.49% |
| 2023-03-31 | $1.59B | $0.14B | 8.78% |
| 2022-12-31 | $1.56B | $0.15B | 9.47% |
| 2022-09-30 | $0.99B | $0.09B | 9.34% |
| 2022-06-30 | $0.96B | $0.11B | 11.76% |
| 2022-03-31 | $0.92B | $0.11B | 12.15% |
| 2021-12-31 | $1.43B | $0.20B | 14.10% |
| 2021-09-30 | $0.47B | $0.13B | 27.06% |
| 2021-06-30 | $0.92B | $0.20B | 21.55% |
| 2021-03-31 | $1.18B | $0.20B | 16.82% |
| 2020-12-31 | $1.12B | $0.18B | 16.07% |
| 2020-09-30 | $3.13B | $0.42B | 13.48% |
| 2020-06-30 | $3.17B | $0.44B | 13.78% |
| 2020-03-31 | $3.46B | $0.50B | 14.36% |
| 2019-12-31 | $3.33B | $0.44B | 13.19% |
| 2019-09-30 | $2.67B | $0.35B | 13.09% |
| 2019-06-30 | $2.34B | $0.29B | 12.16% |
| 2019-03-31 | $2.00B | $0.25B | 12.42% |
| 2018-12-31 | $2.19B | $0.30B | 13.68% |
| 2018-09-30 | $1.48B | $0.40B | 26.95% |
| 2018-06-30 | $1.80B | $0.43B | 24.03% |
| 2018-03-31 | $2.09B | $0.46B | 22.01% |
| 2017-12-31 | $1.94B | $0.45B | 23.32% |
| 2017-09-30 | $3.01B | $0.40B | 13.28% |
| 2017-06-30 | $2.93B | $0.38B | 13.09% |
| 2017-03-31 | $3.04B | $0.39B | 12.68% |
| 2016-12-31 | $3.19B | $0.38B | 11.93% |
| 2016-09-30 | $3.13B | $0.38B | 12.04% |
| 2016-06-30 | $3.33B | $0.37B | 11.10% |
| 2016-03-31 | $3.40B | $0.39B | 11.53% |
| 2015-12-31 | $3.43B | $0.42B | 12.23% |
| 2015-09-30 | $4.11B | $0.48B | 11.75% |
| 2015-06-30 | $4.31B | $0.56B | 13.01% |
| 2015-03-31 | $4.48B | $0.58B | 12.95% |
| 2014-12-31 | $4.62B | $0.59B | 12.65% |
| 2014-09-30 | $4.59B | $0.58B | 12.73% |
| 2014-06-30 | $4.44B | $0.56B | 12.53% |
| 2014-03-31 | $4.31B | $0.54B | 12.56% |
| 2013-12-31 | $4.21B | $0.53B | 12.48% |
| 2013-09-30 | $4.06B | $0.46B | 11.25% |
| 2013-06-30 | $4.00B | $0.42B | 10.52% |
| 2013-03-31 | $3.97B | $0.39B | 9.76% |
| 2012-12-31 | $3.91B | $0.32B | 8.28% |
| 2012-09-30 | $3.06B | $0.24B | 7.73% |
| 2012-06-30 | $2.28B | $0.15B | 6.58% |
| 2012-03-31 | $1.42B | $0.07B | 4.93% |
| 2011-12-31 | $0.69B | $0.05B | 7.06% |
| 2011-09-30 | $0.68B | $0.08B | 11.27% |
| 2011-06-30 | $0.65B | $0.08B | 12.25% |
| 2011-03-31 | $0.58B | $0.06B | 11.02% |
| 2010-12-31 | $0.54B | $0.05B | 9.59% |
| 2010-09-30 | $0.51B | $0.04B | 8.10% |
| 2010-06-30 | $0.50B | $0.04B | 8.35% |
| 2010-03-31 | $0.51B | $0.05B | 8.84% |
| 2009-12-31 | $0.53B | $0.06B | 10.67% |
| 2009-09-30 | $0.55B | $0.07B | 12.30% |
| 2009-06-30 | $0.58B | $0.08B | 13.69% |
| 2009-03-31 | $0.61B | $0.03B | 4.93% |
| 2008-12-31 | $0.60B | $0.03B | 5.46% |
| 2008-09-30 | $0.59B | $0.06B | 10.70% |
| 2008-06-30 | $0.56B | $0.09B | 15.51% |
| 2008-03-31 | $0.52B | $0.14B | 27.01% |
| 2007-12-31 | $0.51B | $0.14B | 27.87% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.605B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.330B | 58.97 |
| Tempus AI (TEM) | United States | $12.432B | 0.00 |
| Doximity (DOCS) | United States | $10.168B | 42.08 |
| Hims & Hers Health (HIMS) | United States | $9.340B | 75.98 |
| IRhythm Technologies (IRTC) | United States | $5.625B | 0.00 |
| Hinge Health (HNGE) | United States | $3.490B | 0.00 |
| Privia Health (PRVA) | United States | $2.882B | 180.23 |
| Heartflow (HTFL) | United States | $2.715B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.377B | 39.32 |
| 10x Genomics (TXG) | United States | $1.898B | 0.00 |
| Omnicell (OMCL) | United States | $1.601B | 32.73 |
| Clover Health Investments (CLOV) | United States | $1.368B | 0.00 |
| Azenta (AZTA) | United States | $1.346B | 58.74 |
| Phreesia (PHR) | United States | $1.319B | 0.00 |
| Schrodinger (SDGR) | United States | $1.309B | 0.00 |
| Claritev (CTEV) | United States | $1.141B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.807B | 0.00 |
| Evolent Health (EVH) | United States | $0.583B | 0.00 |
| Talkspace (TALK) | United States | $0.565B | 113.67 |
| Butterfly Network (BFLY) | United States | $0.563B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.435B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.396B | 0.00 |
| Carlsmed (CARL) | United States | $0.363B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.295B | 0.00 |
| TruBridge (TBRG) | United States | $0.292B | 13.39 |
| CapsoVision (CV) | United States | $0.221B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.212B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.180B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.179B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.167B | 0.00 |
| CareCloud (CCLD) | United States | $0.147B | 8.06 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| Pulmonx (LUNG) | United States | $0.078B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| 111 (YI) | China | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.026B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |